These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16227408)

  • 1. Knockdown of c-Met by adenovirus-delivered small interfering RNA inhibits hepatocellular carcinoma growth in vitro and in vivo.
    Zhang SZ; Pan FY; Xu JF; Yuan J; Guo SY; Dai G; Xue B; Shen WG; Wen CJ; Zhao DH; Li CJ
    Mol Cancer Ther; 2005 Oct; 4(10):1577-84. PubMed ID: 16227408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus-delivered CIAPIN1 small interfering RNA inhibits HCC growth in vitro and in vivo.
    Li X; Pan Y; Fan R; Jin H; Han S; Liu J; Wu K; Fan D
    Carcinogenesis; 2008 Aug; 29(8):1587-93. PubMed ID: 18299278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of c-Met expression inhibits human HCC cells growth and invasion by RNA interference.
    Xie B; Xing R; Chen P; Gou Y; Li S; Xiao J; Dong J
    J Surg Res; 2010 Aug; 162(2):231-8. PubMed ID: 19765730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of c-met-siRNA on the growth and invasion of hepatocellular carcinoma MHCC97-H cells].
    Xie B; Tang DG; Dong JH
    Zhonghua Gan Zang Bing Za Zhi; 2006 Jul; 14(7):499-504. PubMed ID: 16867270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C1GALT1 enhances proliferation of hepatocellular carcinoma cells via modulating MET glycosylation and dimerization.
    Wu YM; Liu CH; Huang MJ; Lai HS; Lee PH; Hu RH; Huang MC
    Cancer Res; 2013 Sep; 73(17):5580-90. PubMed ID: 23832667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The EGFR/ErbB3 Pathway Acts as a Compensatory Survival Mechanism upon c-Met Inhibition in Human c-Met+ Hepatocellular Carcinoma.
    Steinway SN; Dang H; You H; Rountree CB; Ding W
    PLoS One; 2015; 10(5):e0128159. PubMed ID: 26000702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-Met represents a potential therapeutic target for personalized treatment in hepatocellular carcinoma.
    You H; Ding W; Dang H; Jiang Y; Rountree CB
    Hepatology; 2011 Sep; 54(3):879-89. PubMed ID: 21618573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant adenovirus encoding FAT10 small interfering RNA inhibits HCC growth in vitro and in vivo.
    Chen J; Yang L; Chen H; Yuan T; Liu M; Chen P
    Exp Mol Pathol; 2014 Apr; 96(2):207-11. PubMed ID: 24440736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-mediated siRNA targeting c-Met inhibits proliferation and invasion of small-cell lung cancer (SCLC) cells.
    Wang ZX; Lu BB; Yang JS; Wang KM; De W
    J Surg Res; 2011 Nov; 171(1):127-35. PubMed ID: 20338593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of PAK1 gene silencing on proliferation and apoptosis in hepatocellular carcinoma cell lines MHCC97-H and HepG2 and cells in xenograft tumor.
    Zhang ZL; Liu GC; Peng L; Zhang C; Jia YM; Yang WH; Mao L
    Gene Ther; 2018 Jul; 25(4):284-296. PubMed ID: 29802374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The growth and metastasis of human hepatocellular carcinoma xenografts are inhibited by small interfering RNA targeting to the subunit ATP6L of proton pump.
    Lu X; Qin W; Li J; Tan N; Pan D; Zhang H; Xie L; Yao G; Shu H; Yao M; Wan D; Gu J; Yang S
    Cancer Res; 2005 Aug; 65(15):6843-9. PubMed ID: 16061667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FAM9C plays an anti-apoptotic role through activation of the PI3K/Akt pathway in human hepatocellular carcinoma.
    Zhou JD; Shen F; Ji JS; Zheng K; Huang M; Wu JC
    Oncol Rep; 2013 Sep; 30(3):1275-84. PubMed ID: 23836295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.
    Buurman R; Gürlevik E; Schäffer V; Eilers M; Sandbothe M; Kreipe H; Wilkens L; Schlegelberger B; Kühnel F; Skawran B
    Gastroenterology; 2012 Sep; 143(3):811-820.e15. PubMed ID: 22641068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survivin knockdown by short hairpin RNA abrogates the growth of human hepatocellular carcinoma xenografts in nude mice.
    Zhang R; Ma L; Zheng M; Ren J; Wang T; Meng Y; Zhao J; Jia L; Yao L; Han H; Li K; Yang A
    Cancer Gene Ther; 2010 Apr; 17(4):275-88. PubMed ID: 19876077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DLK1 as a potential target against cancer stem/progenitor cells of hepatocellular carcinoma.
    Xu X; Liu RF; Zhang X; Huang LY; Chen F; Fei QL; Han ZG
    Mol Cancer Ther; 2012 Mar; 11(3):629-38. PubMed ID: 22238367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental research of targeting hTERT gene inhibited in hepatocellular carcinoma therapy by RNA interference].
    Zhang PH; Tu ZG; Yang MQ; Huang WF; Zou L; Zhou YL
    Ai Zheng; 2004 Jun; 23(6):619-25. PubMed ID: 15191658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gα12 overexpressed in hepatocellular carcinoma reduces microRNA-122 expression via HNF4α inactivation, which causes c-Met induction.
    Yang YM; Lee CG; Koo JH; Kim TH; Lee JM; An J; Kim KM; Kim SG
    Oncotarget; 2015 Aug; 6(22):19055-69. PubMed ID: 25965999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Met inhibitors attenuate tumor growth of small cell hypercalcemic ovarian carcinoma (SCCOHT) populations.
    Otte A; Rauprich F; von der Ohe J; Yang Y; Kommoss F; Feuerhake F; Hillemanns P; Hass R
    Oncotarget; 2015 Oct; 6(31):31640-58. PubMed ID: 26436697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expressions of the metastasis-associated factors of a new human hepatocellular carcinoma cell line with highly metastatic potential].
    Tian J; Tang Z; Xue Q
    Zhonghua Yi Xue Za Zhi; 1999 Jun; 79(6):470-2. PubMed ID: 11715447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The influence of downregulation of ezrin expression by RNA interference on the growth and metastasis of hepatocellular carcinoma: experiment in vitro].
    Zhang Y; Hu MY; Chen BH; Wang ZJ; Zha XL; Liu KD
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):530-5. PubMed ID: 16681881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.